Updated September 15, 2022 at 10:28 AM ET A new report issued by the Lancet Commission looks at the first two years of the pandemic to consider what the world did right (spoiler: not much), what the world got wrong, and how we can end this public health emergency and prepare for […]
Read More
Researchers have identified an antibody that broadly neutralized all tested SARS-CoV-2 subvariants as well as SARS-CoV-1 in laboratory experiments and several SARS-CoV-2 variants of concern in mice. Because it targets a spike protein area that may be less affected by genetic variations, the newly discovered antibody could better retain potency against emerging […]
Read More
This site provides an integrated, county view of key data for monitoring the COVID-19 pandemic in the United States. It allows for the exploration of standardized data across the country.§ The footnotes describe each data source and the methods used for calculating the metrics. For the most complete and up-to-date data […]
Read More
ACKGROUND The Ad26.COV2.S vaccine is a recombinant, replication-incompetent human adenovirus type 26 vector encoding full-length severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein in a prefusion-stabilized conformation. METHODS In an international, randomized, double-blind, placebo-controlled, phase 3 trial, we randomly assigned adult participants in a 1:1 ratio to receive a […]
Read More
Switching to a different COVID-19 vaccine after a first dose of the Sputnik V C1, ChAdOx1-S, or BBIBP-CorV vaccines can greatly increase immune response while maintaining safety, according to a study published in Cell Reports Medicine. The results provide information for mixing vaccine types in both primary vaccination and vaccine booster schedules, which […]
Read More
People who have received solid organ transplants have a higher risk for severe disease and death from COVID-19, compared with the general population, a new study shows. A multicenter, prospective cohort study of more than 500 solid organ transplant recipients found that the prevalence of severe disease with a high […]
Read More
In nature, microorganisms use CRISPR (clustered regularly interspaced palindromic repeats) and CRISPR-associated (Cas) proteins for antiviral immunity through recognition and destruction of specific DNA sequences. Over the past decade, CRISPR genome editing has been developed to create transformative technologies to treat, cure, and prevent human disease. How CRISPR Works CRISPR […]
Read More
SACRAMENTO – To better align state COVID-19 guidance with the most current federal recommendations, the California Department of Public Health (CDPH) is ending COVID-19 policies that required weekly COVID-19 testing for unvaccinated individuals in high-risk workplaces and schools. Health care facilities, other congregate settings and schools will no longer be […]
Read More
WHO/Europe urges countries to take post COVID-19 condition seriously by urgently investing in research, recovery, and rehabilitation. New modeling conducted for WHO/Europe by the Institute for Health Metrics and Evaluation (IHME) at the University of Washington’s School of Medicine in the United States shows that in the first two years of the […]
Read More
IHME produced its latest COVID-19 model run on September 9. Key takeaways: Global infections peaked in August and are currently declining. We expect infections to increase in the Northern Hemisphere in October through the end of 2022, but we do not expect this to lead to major increases in severe disease and […]
Read More